Core Viewpoint - Shanshan Co., Ltd. is experiencing a decline in performance and control disputes, leading to continuous shareholding reductions by its actual controller due to judicial auctions and debt restructuring [2][6]. Group 1: Shareholding Changes - On June 25, 2025, Wei Wei acquired 13 million shares of Shanshan Co., Ltd. at a price of 8.42 yuan per share, totaling approximately 109 million yuan, through a judicial auction [2][3]. - Following this auction, the actual controller's shareholding ratio decreased to 26.36%, down from over 45% at the end of 2024 [6][8]. - The remaining shares of the major shareholder are under judicial freeze or marking, indicating ongoing financial distress [6]. Group 2: Financial Performance - Shanshan Co., Ltd. reported a significant decline in net profit, dropping from over 20 billion yuan in 2022 to a loss of 7.68 billion yuan in 2024 [8][9]. - The company's total revenue decreased from 217 billion yuan in 2022 to 186.8 billion yuan in 2024, reflecting a downward trend in business performance [9]. Group 3: Company Background and Management Changes - Founded in 1989 and listed in 1996, Shanshan Co., Ltd. transitioned from clothing to lithium battery materials, becoming a leader in the industry [7]. - The company faced management turmoil following the death of its founder, Zheng Yonggang, in 2023, leading to disputes over control between his son and stepmother [7][8]. - The restructuring process initiated by the major shareholder, Shanshan Group, raises concerns about potential changes in company control [6][8].

Core Viewpoint - *ST Huamei is facing a potential change in control due to the planned share transfer by its controlling shareholder, Shanghai Pengsheng, which aims to address the company's financial irregularities and avoid delisting risks [1][3][4]. Group 1: Company Background and Current Situation - *ST Huamei, formerly known as Jilin Huamei Electronics Co., Ltd., specializes in power semiconductor devices and is one of the few domestic companies adopting the IDM model (Integrated Design and Manufacturing) [3]. - The company announced a stock suspension starting June 19, 2025, for no more than two trading days due to the share transfer planning by its largest shareholder, Shanghai Pengsheng, who holds 22.32% of the company's shares [3][4]. - The suspension is primarily driven by the need to mitigate delisting risks associated with non-compliance regarding the disclosure of non-operating fund occupation by the controlling shareholder [3][4]. Group 2: Financial Irregularities and Regulatory Actions - From 2015 to 2023, Shanghai Pengsheng and its affiliates occupied non-operating funds from *ST Huamei, with an outstanding balance of 1.491 billion yuan as of October 15, 2024 [3][4]. - The Jilin Securities Regulatory Bureau issued a notice requiring *ST Huamei and Shanghai Pengsheng to recover the 1.491 billion yuan within six months, with a deadline set for August 12, 2025 [3][4]. - If the recovery is not completed by the deadline, the Shanghai Stock Exchange will suspend the company's stock, and further delays could lead to a delisting decision [4]. Group 3: Financial Performance - Despite governance issues, *ST Huamei reported strong financial recovery, with a revenue of 2.058 billion yuan in 2024, marking an 18.13% year-on-year increase, and a net profit of 128 million yuan, up 246.45% [5]. - In the first quarter of 2025, the company continued its growth trend, achieving a revenue of 643 million yuan, a 29.56% increase year-on-year, and a net profit of 55 million yuan, up 253.08% [7]. - The increase in performance is attributed to the growing demand in the power semiconductor device market [7]. Group 4: Shareholder Dynamics - The composition of the top ten circulating shareholders has changed frequently, with new shareholders entering and others exiting [8]. - As of the first quarter of 2025, Shanghai Pengsheng's shares are fully pledged, indicating potential liquidity issues [8]. - The specifics of the share transfer, including the transaction counterpart, transfer ratio, and price, have not yet been disclosed, but it is seen as a potential new model for resolving the company's financial issues [8].

证券代码：600360 证券简称：*ST 华微 公告编号：2025-044 吉林华微电子股份有限公司 关于筹划控制权变更事项继续停牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 告编号：2025-043）。 （公 截至本公告披露日，上述事项仍处于筹划之中，公司控股股东正与相关方积 极推进本次事项的各项工作，公司预计无法在 2025 年 6 月 23 日（星期一）开市 起复牌。根据《上海证券交易所股票上市规则》 《上海证券交易所上市公司自律监 管指引第 4 号——停复牌》等有关规定，经公司向上海证券交易所申请，本公司 股票将于 2025 年 6 月 23 日（星期一）开市起继续停牌，预计继续停牌时间不超 过 3 个交易日。 停牌期间，公司将根据相关事项进展情况，严格按照有关法律法规的规定和 要求履行信息披露义务。待上述事项确定后，公司将及时发布相关公告并申请复 牌。 重要内容提示： ? 证券停复牌情况：适用 为推动化解公司面临的资金占用规范类退市风险，吉林华微电子股份有限公司（以 下简称"公司"）控股股东上海鹏盛科技实 ...

证券时报记者程丹 私募基金收购上市公司的热潮不断涌现。鸿合科技近日表示，合肥瑞丞私募基金管理有限公司拟以 15.75亿元收购该公司25%股份并取得控制权。这是"并购六条"发布以来，A股市场披露的第6单私募股 权创投基金收购上市公司的案例。 更多私募料参与其中 在现已披露的6单私募股权创投基金收购上市公司的案例中，市场更关注2单，关注度主要集中在两起具 有标杆意义的交易上：一是启明创投拟以4.52亿元收购天迈科技26.10%股份，二是合肥瑞丞私募基金计 划以15.75亿元收购鸿合科技25%股份。这两起交易无论哪宗获得监管部门通过，都将在一定程度上对 行业形成示范效应。 监管部门多次明确表示支持私募基金以产业整合为目的收购上市公司，这与市场需求不谋而合。中央财 经大学资本市场监管与改革研究中心副主任李晓认为，部分上市公司有寻找赋能方和融资方等诉求，希 望有新的伙伴加入，私募基金在产业链上下游往往有众多被投企业，若能入主上市公司，可借助上市公 司主体发挥产业协同效应，实现上市公司做大做强，随着政策红利持续释放，市场需求被充分激发。 年内披露多个收购案例 以年初启明创投拟4.52亿元收购天迈科技26.10%股份为始， ...

停牌核查。 6月11日晚间，*ST亚振（603389）发布关于股票交易风险提示暨停牌核查的公告。公告显示，公司股票于2025年5月6日至6月11日连续26个交易日内日收盘价格涨 幅偏离值累计达到107.83%，多次触及股票交易异常波动。公司股票短期涨幅与同期上证指数、家具制造业存在严重偏离。 为维护投资者利益，公司将就股票交易情况进行核查。经申请，公司股票自2025年6月12日开市起停牌，自披露核查公告后复牌，预计停牌时间不超过3个交易日。 | 证券代码 证券简称 | | 停留能英型 | 停牌起始日 | 停障 | 停牌终止日 | | | --- | --- | --- | --- | --- | --- | --- | | | | | | 期间 | | | | 603389 | *ST 亚提 | A 股 停牌 | 2025/6/12 | | | | 行情数据显示，*ST亚振股票自5月6日起曾连续10个交易日收盘涨停，此后，公司股票震荡上行，自本周来又开启连续涨停态势，本周三个交易日收盘均涨停。截 至今日（6月11日）收盘，公司股票自5月6日以来累计涨超111%。而若把时间再拉长，自今年4月8日盘中创下4.45 ...

Core Viewpoint - Anner's control transfer plan has made substantial progress, ensuring long-term stability and strategic development for the listed company through a combination of share transfer, voting rights waiver, and commitment not to seek control [1][2]. Group 1: Control Transfer Details - The actual controllers, Cao Zhang and Wang Jianqing, hold a combined 27.38% of shares, with Cao holding 19.13% and Wang 8.25% [2]. - The share transfer plan allows for a maximum transfer of 13.03%, with Cao retaining 14.35% of shares, thus remaining the largest shareholder [2]. - Cao's commitment not to seek control aims to eliminate future control disputes and signals stability in the company's control structure, which is beneficial for maintaining stock prices and company image [2][3]. Group 2: Buyer Commitments - The buyer has committed to acquiring an additional 3% of shares through block trading, ensuring their voting rights will not be less than 16.03%, making them the largest shareholder [3]. - This commitment reflects the buyer's confidence in the company's long-term value and their willingness to invest further [3]. Group 3: Market Context - The control transfer is part of a broader trend where multiple listed companies are considering control changes as a strategic upgrade opportunity [3]. - Successful completion of this transaction could help Anner overcome current development challenges and revitalize its brand in the children's clothing industry [3].

Group 1 - The core point of the news is that Shenzhen Anner Co., Ltd. is planning a change in control and has suspended trading for up to two trading days due to the transfer of 13.03% of shares by its controlling shareholders, which may lead to a change in the actual controller [2] - The controlling shareholders, Cao Zhang and Wang Jianqing, are looking to transfer control to a party primarily engaged in investment management, potentially aiming to bring new resources and development opportunities to the company [3] - Anner has faced difficulties in recent years, including failed attempts to promote antiviral fabrics and a terminated acquisition of a big data company due to high premiums and financial pressures, indicating ongoing operational challenges [3] Group 2 - Since its listing in 2017, Anner experienced high growth initially, but has faced declining profitability since 2020, resulting in continuous losses [4] - From 2020 to 2024, Anner's net profit attributable to shareholders has shown significant losses: -47 million, -3 million, -237 million, -100 million, and -115 million, totaling cumulative losses of 502 million [4] - In the first quarter of 2025, Anner reported revenue of 144 million, a year-on-year decline of 27.28%, with a net profit of -8.33 million, a substantial year-on-year drop of 169.01% [4]

安奈儿（002875）6月9日公告，实控人曹璋、王建青与深圳新创源投资合伙企业(有限合伙)签署了《股 权转让协议》及《表决权放弃协议》和《不谋求控制权承诺》，拟将其持有的2776.44万股股份(约占总 股本的13.03%)转让给受让方，转让总价款为人民币4.22亿元。《表决权放弃协议》和《不谋求控制权 承诺》显示，曹璋放弃剩余股份的表决权，不谋求上市公司的实际控制权。根据公告，受让方已于2025 年5月30日支付意向金8千万元，作为股份转让对价款的一部分，并明确剩余转让价款支付安排。 关于转让价款支付安排，受让方已于2025年5月30日支付了意向金8千万元，且公告显示，受让方最迟将 在深交所就本次协议转让出具确认函且缴纳完毕个人所得税之日起十个工作日内完成全部转让价款的支 付。此举传递出新的控股股东三大关键信息：一是对交易诚意的有力佐证，二是对控股安奈儿的坚定决 心，三是对上市公司优质资产的重视程度。这种雷厉风行的资金安排，为上市公司未来发展注入了强心 剂。 控制权变更通常作为企业发展的重要分水岭，往往孕育着转型升级的重大机遇。纵观资本市场，优质股 东赋能上市公司的成功案例不在少数。安奈儿，深耕童装行业29年 ...

今日，菲林格尔大涨9.97%，最新报12.02元/股，总市值42.73亿元。 大牛股，突发停牌核查。 前4个交易日，菲林格尔股价连续涨停，今日尾盘逼近涨停，最终未封住板。 自去年9月以来，菲林格尔股价连续上涨，累计涨超279%，从最低的2.88元/股涨到12.02元/股，股价翻了4倍多。 停牌核查 由于股价涨幅较大，菲林格尔盘后公告，公司股价自5月30日以来大幅上涨，多次触及股票交易异常波动，已严重偏离基本面，为保护投资者利益，将就股 票交易情况进行核查。 经申请，菲林格尔的股票自6月10日开市起停牌，自披露核查公告后复牌。 易主事项引争议 此前，格隆汇曾报道，菲林格尔拟筹划控制权变更事项，以解决公司内部的治理矛盾。 5月31日晚间，菲林格尔发布筹划控制权变更事项的停牌公告。 菲林格尔的实控人丁福如及其一致行动人拟以7.88元/股的价格向安吉以清及其实控人金亚伟合计转让约8887.29万股股份，占总股本的25%。 同时，5%以上股东菲林格尔控股拟以6.73元/股的价格向陕国投·乐盈267号信托、渤源达朗基金、和融联基金合计转让约9676.46万股股份，占总股本的 27.22%。 交易完成后，菲林格尔的德系股东 ...

Core Viewpoint - The proposed change of control for Haiwang Bio has been officially terminated after over three years of planning, with the company deciding to halt the stock issuance to specific parties and the transfer of control [1][3][4]. Group 1: Control Change and Stock Issuance - Haiwang Bio announced the termination of its control change and stock issuance to specific parties, which was intended to be executed through stock transfer and voting rights relinquishment [1][3]. - The control change involved the transfer of 316 million unrestricted circulating shares from the controlling shareholder, Shenzhen Haiwang Group, to Guangdong Silk and Textile Group, representing 12% of the total shares [1][3]. - The termination was formalized through the signing of a termination agreement, with all parties confirming no breach of contract or other liabilities [3][4]. Group 2: Financial Performance - Haiwang Bio has reported consecutive losses over the past three years, with revenues of approximately 37.83 billion, 36.42 billion, and 30.32 billion yuan for 2022 to 2024, and corresponding net losses of about 1.03 billion, 1.69 billion, and 1.19 billion yuan [4]. - In the first quarter of this year, the company experienced a revenue decline of 8.81% year-on-year, totaling approximately 7.38 billion yuan, and a net profit drop of 44.38%, amounting to about 24 million yuan [5]. - The company's high debt ratio is concerning, with an asset-liability ratio of 89.76% reported at the end of the first quarter [5]. Group 3: Future Plans and Market Position - Despite the termination of the control change, Haiwang Bio plans to continue discussions with interested state-owned entities regarding equity cooperation to explore new development opportunities [4]. - The company has indicated that its business operations are proceeding normally and that the termination of the control change will not adversely affect its ongoing operations and stable development [4].